CD177 and neoplasm: TNFR2 is a cell-surface receptor that regulates cell survival and proliferation; however, more recent research has concentrated on TNFR2’s role in regulating tumor immunosuppression.16 17 19 Correspondingly, targeting this receptor has emerged recently as a potential next-generation approach to cancer therapy.